LONDON, March 10, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced they will integrate Clarivate's proprietary regulatory ...

Clarivate Plc (NYSE:CLVT) is one of the best penny stocks to buy according to Reddit. Citi cut the price target on Clarivate Plc (NYSE:CLVT) to $2.80 from $4.25 on March 4, maintaining a Neutral ...

Clarivate is executing a turnaround, with management focusing on debt reduction, divestitures, and share buybacks after years of value-destructive acquisitions. Q4 and FY25 results marked the first ...

Advancing Clarivate strategy to extend proprietary intelligence into enterprise AI ecosystems Bringing Clarivate domain-specific regulatory insights into Claude to support life sciences workflows ...

Wed, March 11, 2026 at 12:24 PM UTC Most investors have never heard of Clarivate. The company operates largely outside mainstream investor attention. While the market fixates on AI darlings trading at ...

The integration uses the open Model Context Protocol (MCP) to connect Clarivate’s proprietary regulatory intelligence with Claude’s natural language reasoning capabilities. As a result, biopharma, ...

Medicines for obesity, diabetes, rare diseases, cancer, and women's health feature among Clarivate's annual round-up of 11 Drugs to Watch this year, but two of them far outstrip the others in sales ...

All right. Well, welcome, everyone. Good morning. Once again, I'm Scott Wurtzel. I cover info services here at Wolfe Research. Excited to be joined by Jonathan Collins, JC, the CFO of Clarivate for a ...

Clarivate (CLVT) Tuesday said that it is currently engaged in active discussions with interested parties to sell its Life Sciences & Healthcare business. Clarivate has retained Morgan Stanley & Co.